| ID | 429 |
|---|
| No | 429 |
|---|
| Brand Name | AVASTIN 100 MG/4 ML |
|---|
| Ingredients | BEVACIZUMAB 100 MG / 4ML |
|---|
| Dosage Form | SOLUTION FOR INFUSION |
|---|
| Primary Packaging | VIAL |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 1 VIAL X 4 ML |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | - METASTATIC COLORECTAL CANCER
- LOCALLY RECURRENT OR METASTATIC BREAST CANCER.
- ADVANCED,METASTATIC OR RECURRENT NON SMALL CELL LUNG CANCER.
- ADVANCED AND/OR METASTATIC RENAL CELL CANCER.
- MALIGNANT GLIOMA ( WHO GRADE IV) GLIOBLASTOMA.
- EPITHELI |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | CLEAR TO SLIGHTLY OPALESCENT, COLORLESS TO PALE BROWN |
|---|
| Note | |
|---|
| License Owner | DKSH LAOS COMPANY LIMITED |
|---|
| Manufacturer | ROCHE DIAGNOSTICS GMBH |
|---|
| Country | GERMANY |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 07 I 3868/13 |
|---|
| FDD Registration Date | 31/03/2023 |
|---|
| Expiry Date | 30/03/2026 |
|---|
